How Generic Companies Can Spot and Evaluate Market Opportunities for High-Barrier APIs
In the generic pharma world, most companies focus on high-volume, crowded markets. It’s a safe approach. But what about the opportunities that are often overlooked? High-barrier APIs — those with significant challenges to development or commercialization — hold unique potential for companies willing to take a calculated risk. This post
